Aytu Biopharma (AYTU) Inventory (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Inventory data on file, last reported at $7.5 million in Q1 2026.

• Inventory for Q1 2026 came in at $7.5 million, down 32.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (down 32.54% YoY), and the FY2025 annual result was $11.4 million, down 5.82% from the prior year.
• Inventory slipped to $7.5 million in Q1 2026 per AYTU's latest filing, from $8.7 million in the prior quarter.
• Over five years, Inventory peaked at $13.9 million in Q1 2022 and troughed at $7.5 million in Q1 2026.
• A 5-year average of $11.7 million and a median of $12.0 million in 2023 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2023: Inventory tumbled 33.6% in 2022, then grew 10.56% in 2023.
• A 5-year view of Inventory shows it stood at $13.0 million in 2022, then advanced by 0.39% to $13.0 million in 2023, then retreated by 14.74% to $11.1 million in 2024, then retreated by 21.91% to $8.7 million in 2025, then retreated by 13.82% to $7.5 million in 2026.
• Business Quant data shows AYTU's Inventory at $7.5 million in Q1 2026, $8.7 million in Q4 2025, and $10.1 million in Q3 2025.